Key Takeaways
- Q4 FY25 earnings for Quantum Computing (QUBT) scheduled for March 2, 2026
- Analysts project a $0.02 per share loss, significantly improved from last year’s $0.47 loss
- Expected revenue of $390K represents substantial growth from Q4 2024’s $62K
- Shares declined 8.4% on February 27, positioned beneath both 50-day and 200-day moving averages
- Implied volatility suggests a potential 14.05% swing following the earnings announcement
Quantum Computing Inc. prepares to unveil its fourth-quarter fiscal 2025 financial results this Monday, March 2, 2026. Investor sentiment turned bearish in the days leading up to the announcement, with shares tumbling 8.4% on February 27 to settle at $8.278.
The session’s trading volume registered approximately 3.37 million shares — a significant 78% decrease from the typical daily average of 15 million shares. While reduced volume during a selloff can indicate limited market participation, additional factors require consideration.
Shares currently trade beneath critical technical indicators, including the 50-day moving average at $10.35 and the 200-day moving average at $13.70. Despite recent weakness, QUBT maintains gains exceeding 39% over the past twelve months, fueled primarily by market enthusiasm surrounding its photonic quantum computing capabilities.
Analyst consensus points to a quarterly loss of $0.02 per share for the fourth quarter of 2025. This projection represents significant improvement compared to the $0.47 per share deficit recorded during the comparable period last year.
Revenue projections stand at $390K, marking a notable increase from the $62K reported in Q4 2024. Although absolute figures remain modest, the trajectory attracts analyst attention.
Luminar Semiconductor Deal Takes Center Stage
Investor focus will likely center on the company’s $110 million cash acquisition of Luminar Semiconductor Inc., formerly held by Luminar Technologies. This strategic transaction aims to enhance QUBT’s technological capabilities and establish more predictable revenue streams.
Market participants anticipate management commentary regarding chip manufacturing schedules, fulfillment of outstanding orders, and initial revenue indicators stemming from the acquisition.
Price Targets See Downward Revisions
Analyst perspectives present a varied outlook. Lake Street analyst Max Michaelis maintained his Buy recommendation while reducing his price objective from $24 to $16 — still suggesting approximately 77% potential appreciation from present levels.
Ascendiant Capital Markets similarly adjusted its target downward from $40 to $25, preserving its Buy rating. Taking a more reserved stance, Wedbush launched coverage with a Neutral designation and $12 target, while Cantor Fitzgerald affirmed its Neutral rating with a $15 price objective.
Rosenblatt Securities initiated coverage this January with a Buy rating and $22 target. The aggregate rating across monitored analysts stands at Moderate Buy, comprising one Strong Buy, two Buy ratings, two Hold ratings, and one Sell recommendation.
The consensus price target across analyst coverage reaches $18.00, implying approximately 99% upside potential from February 27 trading levels.
QUBT demonstrates elevated volatility with a beta coefficient of 3.44, indicating pronounced sensitivity to broader market movements. The company’s market capitalization stands near $1.83 billion, while its negative P/E ratio of -13.40 reflects ongoing pre-revenue operations.
Company insiders control 19.3% of outstanding shares. Chief Operating Officer Milan Begliarbekov divested 2,860 shares on January 7 at $11.85 per share, decreasing his holdings by approximately 10.55%. Institutional investors maintain minimal exposure at just 4.26% ownership.
Options market activity indicates expected price movement of roughly 14.05% in either direction post-earnings.
Fourth-quarter fiscal 2025 financial results will be released before market opening on March 2, 2026.
